跳至主要内容
临床试验/NCT06432127
NCT06432127尚未招募4 期

Role of Ultrasound Guide Greater Occipital Nerve Block at Second Cervical Vertebra in Migraine Headache Prophylaxis in Patients With Failed Oral Prophylaxis Medication : A Randomized Controlled Study in Thailand

Mahidol University1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2024年5月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
108
试验地点
1
主要终点
change of Frequency headache day /month

研究概览

简要总结

The goal of this randomized controlled study in Thailand. is to find if there is a role of local anesthetic greater occipital nerve block at Cervical spine level 2 under ultrasound guide in prophylaxis of episodic migraine and chronic migraine in patients with failed oral prophylaxis medication.

According to guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic and chronic migraine,the primary and secondary outcome were monitoring followed by these research guideline

After informed consent, volunteer will be stratified random into 2 groups of injection agent at unilateral greater occipital nerve block on headache site under US guide by pain physician

  • Normal saline
  • 0.5% bupivacaine the injection was done 2 times between Week 0 and week 4 as to wean off placebo effect the volunteer will be monitor by pain diary at 1 month before intervention at week 0,4,8,12 and follow up at week 24 for Migraine Disability Assessment Test (MIDAS) ,Thai Hospital-Anxiety-depression index(Thai-HADS)

详细描述

  • Neurologist screening candidate volunteers for this study, following the inclusion and exclusion criteria
  • Candidate volunteers attended pain clinic for he protocol detail about this research and informed consent
  • After signing consent, Volunteers would be stratified randomization into 2 groups between Normal saline and bupivacaine
  • Volunteers would be done base line headache diary for 1 month before performing the procedure (Week -4 to week0)
  • At Week 0, Volunteers would be applied local anesthetic cream at skin injection site before done the procedure
  • According to stratified randomization, Pain interventionist and also volunteers would be blinded to the group
  • First Unilateral greater occipital nerve block at Cervical spine level 2 (C2) was done under ultrasound guide (Week0)
  • Telemedicine Follow up at week 2
  • Second Unilateral greater occipital nerve block at C2 level was done under ultrasound guide (Week4)
  • Volunteers would be follow up via telemedicine and done headache diary until 3 months after 1st injection
  • Volunteers would be follow up according to outcome monitoring protocol in Week 0,4,8,12,24

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 -65 years old
  • Diagnosis as episodic migraine or chronic migraine and had indication to use migraine prophylaxis
  • Volunteer prefer to use research procedure as first choice of migraine prophylaxis
  • Volunteer already had migraine prophylaxis treatment but still has the one of these following problem 4.1 Frequency of migraine attack more than 4 times/month 4.2 Severe migraine headache & disturb daily life in spite of using migraine prophylaxis 4.3 Having migraine medication side effect, either from prophylaxis or acute attack medication and cannot titration medication dosage 4.4 migraine attack not improved as using many migraine prophylaxis medications 4.5 Having contra-indication to use prophylaxis migraine medication or standard prophylaxis procedure such as botulinum toxin 4.6 Cannot take prophylaxis medication daily (low compliance) 4.7 Had financial problems in using standard prophylaxis migraine medication or procedure 4.8 Medication overuse headache

排除标准

  • Had these type of headache in combination with migraine
  • cervicogenic headache
  • occipital neuralgia
  • secondary headache
  • Had contraindication on greater occipital nerve block injection at cervical spine level 2 under ultrasound-guided such as skin infection in needle site
  • Allergy to local anesthetic
  • Uncontrolled psychiatric disorder in 3 months before attending research
  • Cannot understand or reading, writing Thai language

研究组 & 干预措施

Placebo

Placebo Comparator

Use Normal saline 3 ml as the injection agent

干预措施: Placebo (Drug)

Bupivacaine

Experimental

Use 0.5% Bupivacaine 3ml as the injection agent

干预措施: Bupivacaine (Drug)

结局指标

主要结局

change of Frequency headache day /month

时间窗: at Week 0,4,8,12,24 compared to base line at 1 months before injection procedure

by using headache diary

change of migraine attack day /month from headache diary

时间窗: at Week 0,4,8,12,24 compared to base line at 1 months before injection procedure

by using headache diary

次要结局

  • Healthcare outcomes/quality of life(at Week 0,4,8,12,24 compared to base line at 1 months before injection procedure)
  • Thai-Migraine Disability Assessment(at Week 12,24 compare to baseline)
  • change in severity of headache day per month (decrease of moderate-severe pain)(at Week 0,4,8,12,24 compared to base line at 1 months before injection procedure)
  • Thai-Hospital Anxiety and Depression Scale(at Week 0,4,8,12,24 compared to base line at 1 months before injection procedure)
  • Patient's reported outcome measurement (PGI-C)(at Week 0,4,8,12,24 compared to base line at 1 months before injection procedure)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验